Education
About Us
Working with TipRanks
Follow Us
Eric Pauwels Insider Profile
4 Followers
Eric Pauwels, President, NPS Pharma Int'l at NPS Pharma, holds 70.37K shares in PTC Therapeutics (Ticker: PTCT), holds 0.00 shares in NPS Pharma (Ticker: NPSP), holds 30.00K shares in Accuray (Ticker: ARAY).
Eric Pauwels NPS Pharma (NPSP)President, NPS Pharma Int'l
NPS Pharma (NPSP)
President, NPS Pharma Int'l
Ranked #59,968 out of 105,219 Corporate Insiders
Profitable Transactions
9 out of 17 Profitable Transactions
Average Return
-1.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Eric Pauwels holds in companies
Most Profitable Insider Trade
The most profitable trade made by Eric Pauwels
Eric Pauwels's Trading History
NPS Pharma
Feb 24, 2015
―
Uninformative Sell
1.38M
―
PTC Therapeutics
Dec 19, 2025
CBO
Uninformative Buy
2.70M
$5.53M
Accuray
Mar 01, 2011
SVP Chief Marketing Officer
Uninformative Buy
―
$27.21K
List of latest transactions for each holding click on a transaction to see Eric Pauwels's performance on stock
You May Also Like
Eric Pauwels insider profile FAQ
What is the percentage of profitable transactions made by Eric Pauwels?
The percentage of profitable transactions made by Eric Pauwels is 53%.
What is the average return per transaction made by Eric Pauwels?
The average return per transaction made by Eric Pauwels is -1.90%.
What stocks does Eric Pauwels hold?
Eric Pauwels holds: NPSP, PTCT, ARAY stocks.
What was Eric Pauwels’s latest transaction?
Eric Pauwels latest transaction was an Uninformative Buy of $2.70M.
What was Eric Pauwels's most profitable transaction?
Eric Pauwels’s most profitable transaction was an Informative Sell of PTCT stock on April 20, 2023. The return on the trade was 52.90%.
What is Eric Pauwels's role in NPS Pharma?
Eric Pauwels's role in NPS Pharma is President, NPS Pharma Int'l.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.